Table 1.
Future Research Perspectives |
---|
Evaluation of PEC characteristics after miR193a inhibition in transgenic mice with miR193a-induced FSGS |
Analysis of miR193a profile of the PECs and podocytes in animal models of crescentic GN during active disease and after resolution |
Validation of miR193a profile in primary FSGS by other investigators |
Comparison of miR193a profile in animals with transgenic expression of APOL1G0 and those without APOL1G0 |
Long-term tumorigenesis effects of miR193a inhibition in animal models |